CXCL9 and neoplasm: Interferon cascade activation induces the production of chemokines, such as CXCL9, which promotes the recruitment of CD8+ T cells to the tumor microenvironment and stimulates the expression of CXCL13, intensifying immune infiltration and improving the response to checkpoint inhibitor treatments [28].